FDA.reportPublic FDA data

ASCENIV 10 % per 50 ML Injection

RxCUI
2123042
RxNorm name
ASCENIV 10 % per 50 ML Injection
Display name
ASCENIV 10 % per 50 ML Injection
Full name
ASCENIV 10 % per 50 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125590AscenivImmune Globulin Intravenous, Human-slra351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d74f4360-3b51-496c-96fb-84c3976958d2ASCENIV 10 % in 50 ML Injection [PSN] · 50 ML immune globulin intravenous (human) - slra 100 MG/ML Injection [Asceniv] [SBD] · 50 ML Asceniv 100 MG/ML Injection [SY] · ASCENIV 10 % per 50 ML Injection [SY]412These highlights do not include all the information needed to use ASCENIV ™ safely and effectively. See full prescribing information for ASCENIV. ASCENIV (immune globulin intravenous, human – slra) 10% Liquid Initial U.S. Approval: 201920260430